Avoro Capital Advisors
Investor profile
Venture capital
Avoro Capital Advisors has backed 2 European tech companies across 2 funding rounds between 2021 and 2023, joining rounds totalling €207M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: Avoro Ventures
Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2023
3 yrs
Total round €
€207M
sum of rounds joined
Deals by year
distinct rounds / yearAvoro Capital Advisors — deals by year — interactive chart.
Data table
| Avoro Capital Advisors — deals by year | |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
Top sectors
by dealsAvoro Capital Advisors — top sectors — interactive chart.
Data table
| Avoro Capital Advisors — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsAvoro Capital Advisors — stages — interactive chart.
Data table
| Avoro Capital Advisors — stages | |
|---|---|
| Series B | 1 |
| Series C | 1 |
Countries
by dealsAvoro Capital Advisors — countries — interactive chart.
Data table
| Avoro Capital Advisors — countries | |
|---|---|
| Denmark | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemab Therapeutics | Denmark | 1 | €127M |
| Monte Rosa | Switzerland | 1 | €80M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Monte Rosa | Series C | €80M | 2021-03 |